Magnetic Resonance Cholangiopancreatography to Evaluate Improvement Effect of FXR Regulating Bile Acid on Hepatocellular Carcinoma with Obstructive Jaundice

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Group</td><td class="align_center">Cases</td><td class="align_center">Age/years old</td><td class="align_center">Male/cases</td><td class="align_center">Female/cases</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">Study group</td><td class="align_center">48</td><td class="align_center">52.61 ± 9.59</td><td class="align_center">20</td><td class="align_center">28</td></tr><tr><td class="align_left">Control group</td><td class="align_center">10</td><td class="align_center">46.74 ± 7.92</td><td class="align_center">5</td><td class="align_center">5</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>General information of patients.</div>

Contrast Media & Molecular Imaging

tab1

Table 1

Table 1: Magnetic Resonance Cholangiopancreatography to Evaluate Improvement Effect of FXR Regulating Bile Acid on Hepatocellular Carcinoma with Obstructive Jaundice 

Table 1 | Magnetic Resonance Cholangiopancreatography to Evaluate Improvement Effect of FXR Regulating Bile Acid on Hepatocellular Carcinoma with Obstructive Jaundice 